FDA
approval
· 2023-05-23
FDA Approved: REGADENOSON — Original Application (Baxter Healthcare Corporation)
Summary
FDA approved Regadenoson (REGADENOSON) as a pharmacologic stress agent for myocardial perfusion imaging in adults unable to perform exercise testing, marking Ba…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for REGADENOSON (REGADENOSON)